| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 21.4% | Morgan Stanley | → $40 | Upgrades | Equal-Weight → Overweight |
| 09/26/2023 | -2.88% | Citigroup | $30 → $32 | Maintains | Neutral |
| 09/25/2023 | -2.88% | Citigroup | $30 → $32 | Maintains | Neutral |
| 08/01/2023 | -24.13% | Morgan Stanley | $25 → $25 | Reiterates | Equal-Weight → Equal-Weight |
| 07/31/2023 | -21.09% | BMO Capital | $27 → $26 | Maintains | Market Perform |
| 07/12/2023 | -56.42% | GLJ Research | $13.85 → $14.36 | Maintains | Sell |
| 07/05/2023 | -21.09% | Exane BNP Paribas | → $26 | Downgrades | Outperform → Neutral |
| 06/21/2023 | -24.13% | Morgan Stanley | → $25 | Reiterates | → Equal-Weight |
| 06/01/2023 | -42.34% | Wolfe Research | → $19 | Downgrades | Peer Perform → Underperform |
| 05/23/2023 | -27.16% | JP Morgan | → $24 | Initiates Coverage On | → Neutral |
| 05/22/2023 | -24.13% | Morgan Stanley | $30 → $25 | Maintains | Equal-Weight |
| 05/01/2023 | -18.06% | BMO Capital | $30 → $27 | Maintains | Market Perform |
| 05/01/2023 | -8.95% | Morgan Stanley | $33 → $30 | Maintains | Equal-Weight |
| 03/20/2023 | -39.3% | Wolfe Research | → $20 | Upgrades | Underperform → Peer Perform |
| 03/20/2023 | 0.15% | Morgan Stanley | $31 → $33 | Maintains | Equal-Weight |
| 02/10/2023 | -57.97% | GLJ Research | $42.75 → $13.85 | Downgrades | Buy → Sell |
| 02/08/2023 | -5.92% | Morgan Stanley | $20 → $31 | Maintains | Equal-Weight |
| 02/06/2023 | -21.09% | Goldman Sachs | $23 → $26 | Maintains | Sell |
| 02/06/2023 | 0.15% | BMO Capital | $25 → $33 | Maintains | Market Perform |
| 12/19/2022 | -39.3% | Morgan Stanley | $19 → $20 | Maintains | Equal-Weight |
| 11/02/2022 | -42.34% | Morgan Stanley | $21.5 → $19 | Maintains | Equal-Weight |
| 10/06/2022 | -45.37% | Goldman Sachs | $21 → $18 | Maintains | Sell |
| 09/16/2022 | 12.29% | Credit Suisse | $44 → $37 | Maintains | Outperform |
| 08/01/2022 | -34.75% | Morgan Stanley | $20 → $21.5 | Maintains | Equal-Weight |
| 07/06/2022 | -39.3% | Morgan Stanley | $27 → $20 | Maintains | Equal-Weight |
| 06/17/2022 | -30.2% | BMO Capital | $30 → $23 | Maintains | Market Perform |
| 06/17/2022 | 33.54% | Credit Suisse | $49 → $44 | Maintains | Outperform |
| 06/14/2022 | -15.02% | JP Morgan | $34 → $28 | Maintains | Underweight |
| 05/31/2022 | -33.23% | Goldman Sachs | $36 → $22 | Maintains | Sell |
| 05/11/2022 | -18.06% | Morgan Stanley | $31 → $27 | Maintains | Equal-Weight |
| 03/24/2022 | 0.15% | JP Morgan | $30 → $33 | Maintains | Underweight |
| 03/22/2022 | -5.92% | Goldman Sachs | $28 → $31 | Maintains | Sell |
| 03/07/2022 | -5.92% | Morgan Stanley | $21 → $31 | Upgrades | Underweight → Equal-Weight |
| 01/11/2022 | -27.16% | Wolfe Research | → $24 | Downgrades | Peer Perform → Underperform |
| 11/17/2021 | -18.06% | Wolfe Research | → $27 | Initiates Coverage On | → Peer Perform |
| 10/18/2021 | -48.41% | Morgan Stanley | $35 → $17 | Downgrades | Overweight → Underweight |
| 10/14/2021 | -24.13% | Argus Research | → $25 | Upgrades | Hold → Buy |
| 10/06/2021 | -36.27% | Goldman Sachs | $34 → $21 | Downgrades | Neutral → Sell |
| 06/16/2021 | 24.43% | JP Morgan | → $41 | Assumes | Neutral → Underweight |
| 06/04/2021 | -8.95% | UBS | $15 → $30 | Upgrades | Sell → Neutral |
| 05/11/2021 | -2.88% | Morgan Stanley | $24 → $32 | Upgrades | Equal-Weight → Overweight |
| 05/04/2021 | 6.22% | Credit Suisse | $15 → $35 | Upgrades | Underperform → Outperform |
| 04/09/2021 | -24.13% | Goldman Sachs | → $25 | Initiates Coverage On | → Neutral |
| 03/15/2021 | — | Argus Research | Downgrades | Buy → Hold | |
| 03/12/2021 | -27.16% | Morgan Stanley | $18 → $24 | Maintains | Equal-Weight |
| 02/17/2021 | -45.37% | Morgan Stanley | $17 → $18 | Maintains | Equal-Weight |
| 01/08/2021 | -15.02% | Deutsche bank | → $28 | Upgrades | Sell → Buy |
| 12/09/2020 | -48.41% | Morgan Stanley | → $17 | Initiates Coverage On | → Equal-Weight |
| 11/24/2020 | -47.5% | GLJ Research | $7.36 → $17.3 | Upgrades | Hold → Buy |
| 08/04/2020 | -78.76% | Citigroup | $8 → $7 | Maintains | Neutral |
| 06/09/2020 | -60.55% | GLJ Research | → $13 | Upgrades | Sell → Hold |
| 05/14/2020 | -87.86% | UBS | $7 → $4 | Maintains | Sell |
| 04/17/2020 | -81.79% | JP Morgan | $9 → $6 | Maintains | Neutral |
| 04/15/2020 | -90.9% | GLJ Research | $4 → $3 | Maintains | Sell |
| 01/14/2020 | -72.69% | Goldman Sachs | → $9 | Reinstates | → Sell |
| 11/14/2019 | -78.76% | UBS | $9 → $7 | Maintains | Sell |
| 11/05/2019 | — | Argus Research | Downgrades | Buy → Hold | |
| 10/31/2019 | — | Berenberg | Downgrades | Buy → Hold | |
| 09/23/2019 | -57.51% | JP Morgan | $26 → $14 | Downgrades | Overweight → Neutral |
| 09/19/2019 | -75.72% | Credit Suisse | $9 → $8 | Maintains | Underperform |
| 09/19/2019 | -72.69% | Macquarie | $18 → $9 | Downgrades | Outperform → Underperform |
| 06/04/2019 | -66.62% | Goldman Sachs | $17 → $11 | Downgrades | Neutral → Sell |
| 05/30/2019 | — | Deutsche Bank | Downgrades | Hold → Sell | |
| 05/08/2019 | -69.65% | UBS | → $10 | Downgrades | Neutral → Sell |
| 04/11/2019 | — | B of A Securities | Downgrades | Buy → Underperform | |
| 04/09/2019 | -60.55% | Credit Suisse | $21 → $13 | Downgrades | Neutral → Underperform |
| 02/21/2019 | — | Berenberg | Upgrades | Hold → Buy | |
| 01/28/2019 | — | Morgan Stanley | Upgrades | Underweight → Equal-Weight | |
| 01/22/2019 | — | Jefferies | Downgrades | Buy → Hold | |
| 01/18/2019 | — | Longbow Research | Downgrades | Buy → Neutral | |
| 01/10/2019 | -30.2% | Citigroup | $40 → $23 | Downgrades | Buy → Neutral |
| 01/09/2019 | -33.23% | Cowen & Co. | → $22 | Initiates Coverage On | → Market Perform |
| 01/08/2019 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
| 12/10/2018 | -33.23% | UBS | $28 → $22 | Upgrades | Sell → Neutral |
| 11/06/2018 | 21.4% | Citigroup | $45 → $40 | Maintains | Buy |
| 11/05/2018 | 0.15% | BMO Capital | $36 → $33 | Maintains | Market Perform |
| 10/11/2018 | 6.22% | Seaport Global | → $35 | Initiates Coverage On | → Buy |
| 10/02/2018 | 6.22% | Deutsche Bank | $47 → $35 | Downgrades | Buy → Hold |
What is the target price for United States Steel (X)?
The latest price target for United States Steel (NYSE: X) was reported by Morgan Stanley on October 2, 2023. The analyst firm set a price target for $40.00 expecting X to rise to within 12 months (a possible 21.40% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for United States Steel (X)?
The latest analyst rating for United States Steel (NYSE: X) was provided by Morgan Stanley, and United States Steel upgraded their overweight rating.
When is the next analyst rating going to be posted or updated for United States Steel (X)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of United States Steel, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for United States Steel was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
Is the Analyst Rating United States Steel (X) correct?
While ratings are subjective and will change, the latest United States Steel (X) rating was a upgraded with a price target of $0.00 to $40.00. The current price United States Steel (X) is trading at is $32.95, which is within the analyst's predicted range.